Latest Vulnerable plaque Stories
GUARDaHEART, a non-profit foundation committed to raising awareness about Heart Disease prevention, held a heart health event on March 20, 2013 at the State Capitol of California. Sacramento, CA (PRWEB) March 22, 2013 GUARDaHEART, a non-profit foundation committed to raising awareness about Heart Disease prevention, held a heart health event on March 20, 2013 at the State Capitol hosted by Assemblyman Don Wagner, R-Irvine and Assemblywoman Diane Harkey, R-Dana Point to celebrate the State...
SACRAMENTO, Calif., March 22, 2013 /PRNewswire/ -- GUARDaHEART, a non-profit foundation committed to raising awareness about Heart Disease prevention, held a heart health event on March 20, 2013 at the State Capitol hosted by Assemblyman Don Wagner, R-Irvine and Assemblywoman Diane Harkey, R-Dana Point to celebrate the State of California's Master Plan for Heart Disease and Stroke Prevention and Treatment. The special event took place at the State Capitol, where medical doctors and...
IRVINE, Calif., Feb. 12, 2013 /PRNewswire/ -- Aviir Inc., a biotechnology company dedicated to the prevention of cardiovascular disease through innovative laboratory tests, today announced that its current investor group was joined by Partners & Partners to fund the second $10 million tranche of a total possible financing of $30 million. The financing was triggered by the company's successful achievement of revenue milestones ahead of schedule and the final investment of $10...
IRVINE, Calif., Nov. 15, 2012 /PRNewswire/ -- Aviir Inc., a biotechnology company dedicated to the prevention of cardiovascular disease through innovative laboratory tests, announced today that a new peer reviewed study published in the November issue of Current Medical Research and Opinion demonstrated that its MIRISK VP (formerly TruRisk(TM)) Assessment is an improved method of determining who is likely to suffer from a heart attack within five years, allowing preventive measures...
IRVINE, Calif., Aug. 17, 2012 /PRNewswire/ -- Guard A Heart Foundation, a non-profit organization, raising awareness for cardiovascular disease by educating individuals about the dangers of vulnerable plaque, is pleased to announce the appointment of Dr. Bahar Sedarati as its Scientific Spokesperson and Ambassador. Dr. Sedarati's responsibilities will include supporting Guard A Heart through peer to peer speaking engagements and contributing her expertise through education and...
Study finds mechanism behind recognized risk, suggests new treatment strategy A heart attack doesn't just damage heart muscle tissue by cutting off its blood supply, it also sets off an inflammatory cascade that worsens underlying atherosclerosis, actively increasing the risk for a future heart attack. These findings from a study receiving advance online publication in Nature suggest an important new therapeutic strategy for preventing heart attacks and strokes, both of which are caused...
Like Yin and Yang, the two proteins have opposite effects in the walls of blood vessels. AIF-1 stimulates undesirable formation of new cells after a vascular injury, and IRT-1 has the opposite effect. It is the latter, IRT-1, that Maria Gomez wants to use to stop a dangerous development in the artery, together with researchers at Lund University Diabetes Centre in Sweden and Temple University in the USA. They have already had success in animal experiments. “After an arterial injury, the...
Researchers at Emory University School of Medicine have identified hepcidin, a hormone that regulates iron levels in the body, as a potential target for treating atherosclerosis. Suppressing hepcidin is a way to reduce the iron levels inside the white blood cells found in arterial plaques. Reducing iron levels pushes those cells to clean up harmful cholesterol in a process called "reverse cholesterol transport," interfering with atherosclerosis, researchers have found. The data is being...
In human coronary arteries, atherosclerotic plaques tend to spread downstream because of the changes in blood flow patterns the plaque causes, researchers have found. This insight comes from a study of fluid dynamics in the arteries of people being treated for coronary artery disease. The results are being presented Tuesday, Nov. 15 at the American Heart Association Scientific Sessions meeting in Orlando. The study leader is Habib Samady, MD, professor of medicine and director of...
Dual imaging approach could improve diagnosis, treatment of coronary artery disease A new device that combines two microimaging technologies can reveal both the detailed anatomy of arterial linings and biological activities that, in coronary arteries, could indicate the risk of heart attacks or the formation of clots in arterial stents. In their report receiving early online release in Nature Medicine, Massachusetts General Hospital (MGH) investigators describe using an intra-arterial...
